• AgeneBio Obtains National Institute on Aging Grant for Phase 3 Trial of Its Alzheimer’s Therapy AGB101
  • NIH Awards $1.8M to Pain Therapeutics for Work Toward a Diagnostic Blood Test for Alzheimer’s
  • Alzheimer’s Disease Cooperative Study, Biohaven Jointly Launch Clinical Trial for Trigriluzole
  • People at Risk for Alzheimer’s Wanted for Major Study Testing Possible Preventive Therapies
  • Infection by Parasite Could Be Linked to Development of Alzheimer’s, Study Reports
  • Women with Genetic Risk of Alzheimer’s More Likely than Men to Develop It Between Age 65 and 75, Study Finds
  • Breast Cancer Approach to Alzheimer’s Trial Design Could Improve Results, Scientists Contend
  • Link Between Lysosomes and Granulins in Brain Cells May Aid Understanding of Alzheimer’s
  • Maryland Students Win National Prize with Tool to Detect Alzheimer’s Before Symptoms Arise
  • Alzheimer’s Breakthrough Team to Compete for XPrize Launch of Effort for Early Detection
  • Blood Test Seen to Identify Alzheimer’s with Accuracy, Including Early-stage Disease
  • Anavex Obtains U.S. Patent on Combinations of Anavex 2-73 and Donepezil to Protect Nerve Cells